← Leaderboards
Cyndy Davis Sanberg
Saneron Ccel Therapeutics, Inc.
$322,012
Attributed
$494,023
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $237K · FY2008–09$250K$187.5K$125K$62.5K$0
'08
'09
Funding mix
By agency
NIH$494,023 · 3
By mechanism
R43$494,023 · 3
Top collaborators
- Jun Tan3 shared
Most similar at Saneron Ccel Therapeutics, Inc.
Same institution · by research overlap
- Don F. Cameron$133,060
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsSecretaseImpaired CognitionMutantPathologyS DiseaseCerebrumGenerationsMouse ModelCognitiveEuthanasiaAmyloid Precursor Protein ProcessingProductionProphylactic TreatmentBiochemicalCellsFoundationsFutureComplexIn VivoAmyloidosisClinical TrialsAlzheimer&AposSite
Grant awards (4)
DiosMemTM, a natural gamma-secretase inhibitor, opposes AD pathogenesis$165,254
R43 · FY2009 · AG
Oral administration of TeaMemTM inhibits Alzheimer's disease pathogenesis$71,782
R43 · FY2009 · AT
Oral administration of TeaMemTM inhibits Alzheimer's disease pathogenesis$106,987
R43 · FY2008 · AT
Sertoli Treated Cord Blood for Spinal Cord Injury$150,000
R43 · FY2004 · NS